Impact of the COVID-19 pandemic on blood pressure control: a nationwide home blood pressure monitoring study

Feitosa, Fabiana G. A. M.; Feitosa, Audes D. M.; Paiva, Annelise Machado Gomes de; Mota‐Gomes, Marco A.; Barroso, Weimar Sebba; Miranda, Roberto Dischinger; Barbosa, Eduardo; Brandão, Andréa Araújo; Lima-Filho, José Luiz de; Spósito, Andrei C.; Coca, António; Nadruz, Wilson

doi:10.1038/s41440-021-00784-1

Cited by 42 publications

(38 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…27 Recent descriptive data from 24 US health systems also showed that the proportion of uncontrolled BP averaged across health systems dropped from 60.5% in 2019 to 53.3% during the pandemic. 28 Conversely, studies conducted in France, 29 Italy, 30,31 and Brazil 32 have found either no change or improvement in BP during the pandemic. While informative, these studies may suffer from several limitations.…”

Section: Discussionmentioning

confidence: 99%

Changes in Blood Pressure Outcomes Among Hypertensive Individuals During the COVID-19 Pandemic: A Time Series Analysis in Three US Healthcare Organizations

et al. 2022

View full text Add to dashboard Cite

Background: The COVID-19 pandemic may have negatively affected medical care for and self-management of chronic hypertension. We sought to examine the impact of the pandemic on blood pressure (BP) among individuals with hypertension. Methods: Using an interrupted time series analysis, we compared the level and trend (slope) of BP outcomes before the public health emergency declaration (prepandemic period: August 2018 through January 2020) versus after the stay-at-home orders (pandemic period: April 2020 through November 2020) among adults with hypertension followed at 3 large health systems (n=137 593). Outcomes include systolic and diastolic BP recorded in electronic health records and the proportion of individuals with BP <140/90 mm Hg. Results: The number of BP measurements substantially dropped early in the pandemic and then gradually increased. During the pandemic period, systolic and diastolic BP increased by 1.79 mm Hg (95% CI, 1.57–2.01; P <0.001) and 1.30 mm Hg (95% CI, 1.18–1.42; P <0.001), respectively, compared with the prepandemic period. Similarly, the proportion of patients with controlled BP decreased by 3.43 percentage points (95% CI, −3.97 to −2.90; P <0.001). A trend showing increasing control in the prepandemic period (+3.19 percentage points per year [95% CI, +2.96 to +3.42]; P <0.001) flattened during the pandemic period (+0.27 percentage points per year [95% CI, −0.81 to −1.37]; P =0.62). Conclusions: The first 8 months of the pandemic were associated with worsening BP outcomes among individuals with hypertension. Opportunities to ensure ongoing access to health care with telemedicine and home BP monitoring may mitigate adverse impacts on BP control for future disasters/emergencies.

show abstract

Section: Discussionmentioning

confidence: 99%

Changes in Blood Pressure Outcomes Among Hypertensive Individuals During the COVID-19 Pandemic: A Time Series Analysis in Three US Healthcare Organizations

et al. 2022

View full text Add to dashboard Cite

show abstract

“…In contrast this same study did not find differences in blood pressure between 2019 and January-March 2020. Conflicting to these findings are the findings in Brazil (74), Italy (75), and France (76) that did not demonstrate worsening blood pressure control during the early period of the pandemic. In the study by Feitosa et al those that here already on pharmacological therapy for hypertension were found to have improved blood pressure readings in the early period of the pandemic (74).…”

Section: Hypertensionmentioning

confidence: 84%

Temporal trends in cardiovascular care: Insights from the COVID-19 pandemic

Kodsi

Bhat

2022

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

In response to the ongoing COVID-19 pandemic, public health care measures have been implemented to limit spread of the contagion and ensure adequate healthcare resource allocation. Correlating with these measures are observed changes in the incidence and outcomes of cardiovascular conditions in the absence of COVID-19 infection. The pandemic has resulted in a reduction in acute coronary syndrome, heart failure and arrhythmia admissions but with worsened outcomes in those diagnosed with these conditions. This is concerning of an underdiagnosis of cardiovascular diseases during the pandemic. Furthermore, cardiovascular services and investigations have decreased to provide healthcare allocation to COVID-19 related services. This threatens an increasing future prevalence of cardiovascular morbidity in healthcare systems that are still adapting to the challenges of a continuing pandemic. Adaption of virtual training and patient care delivery platforms have been shown to be useful, but adequate resources allocation is needed to ensure effectiveness in vulnerable populations.

show abstract

“…Estudo brasileiro recente com mais de 50 000 indivíduos avaliados não encontrou influência da pandemia sobre as taxas de controle pela PAC ou pela MRPA. 14 Os idosos, em geral com maior dificuldade para o controle da PA, 1,2,12 mostraram aumento das taxas de controle pela PAC <130/80mmHg e pela MRPA. Estudos com hipertensos idosos têm enfatizado os benefícios de reduções mais intensas da PA na proteção CV.…”

Section: Resultsunclassified

Monitorização Residencial da Pressão Arterial e Controle Pressórico em Hipertensos Tratados

Brandão¹,

Barroso²,

Feitosa³

et al. 2022

Arquivos Brasileiros De Cardiologia

View full text Add to dashboard Cite

Impact of the COVID-19 pandemic on blood pressure control: a nationwide home blood pressure monitoring study

Cited by 42 publications

References 12 publications

Changes in Blood Pressure Outcomes Among Hypertensive Individuals During the COVID-19 Pandemic: A Time Series Analysis in Three US Healthcare Organizations

Changes in Blood Pressure Outcomes Among Hypertensive Individuals During the COVID-19 Pandemic: A Time Series Analysis in Three US Healthcare Organizations

Temporal trends in cardiovascular care: Insights from the COVID-19 pandemic

Monitorização Residencial da Pressão Arterial e Controle Pressórico em Hipertensos Tratados

Contact Info

Product

Resources

About